ClinicalTrials.Veeva

Menu

Body Composition, Bone Health and Hormonal Status in HIV-1-infected Individuals (BONBO)

U

Universitair Ziekenhuis Brussel

Status

Terminated

Conditions

HIV-1
Treatment-naïve

Treatments

Other: Resting energy expenditure measurement
Radiation: DXA scan
Other: Achilles bone US
Other: Medical body composition measurements

Study type

Observational

Funder types

Other

Identifiers

NCT03708289
UZB BONBO

Details and patient eligibility

About

Improved survival of people living with HIV has resulted in an increased occurrence of other comorbidities, such as cardiovascular, renal, bone and endocrine pathologies.

The data that is currently available on cART-associated changes in bone mineral density, body composition and hormonal values is short-term and mainly derived from patients initiating cART in accordance with previous treatment guidelines. As current guidelines recommend earlier cART initiation and as PI-based regimens are becoming less frequently used, a favorable outcome on bone health, body composition measures and endocrine status might be expected.

This study will therefore prospectively document alterations in bone mineral density, body composition and endocrine status in HIV-infected patients in whom, in the current treatment era, an INSTI-based cART regimen is initiated as a first line regimen.

Full description

Patients will be included at the initiation of cART. The follow up for this study is planned to fit within the routine follow up consultations and includes some extra experimental investigations, such as the medical body composition measurements, resting energy expenditure measurement, Achilles bone ultrasonometer and DXA scans. Standard blood and urine samples will be taken, including standard analyses and some extra analyses for the study.

Physical activity will be monitored for 5 consecutive days using a bracelet device while patients will be asked to record their food intake using a standardized diet agenda.

Total follow up time will be 144 weeks and includes 12 visits in total.

Enrollment

120 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented and confirmed HIV-1-infection
  • Aged 18 years or above
  • Naïve to anti-retroviral treatment, unless anti-retrovirals were taken in the context of occupational or non-occupational post-exposure prophylaxis or in the context of prevention of mother-to-child transmission
  • Willingness to sign the written informed consent

Exclusion criteria

  • Pregnancy and breastfeeding
  • Patients receiving medical care through an 'emergency care package'

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems